Scharberg EA, Olsen C, Bugert P. The H blood group system. Immunohematology 2016;32:112–8.ScharbergEAOlsenCBugertPThe H blood group system201632112810.21307/immunohematology-2019-056Search in Google Scholar
Daniels G. Human blood groups. Oxford, U.K.: Blackwell Scientific, 2002.DanielsGOxford, U.KBlackwell Scientific200210.1002/9780470987018Search in Google Scholar
Spitalnik PF, Spitalnik SL. The P blood group system: biochemical, serological, and clinical aspects. Transfus Med Rev 1995;9:110–22.SpitalnikPFSpitalnikSLThe P blood group system: biochemical, serological, and clinical aspects199591102210.1016/S0887-7963(05)80050-1Search in Google Scholar
Schonewille H, van de Watering LM, Brand A. Additional red blood cell alloantibodies after blood transfusions in a nonhematologic alloimmunized patient cohort: is it time to take precautionary measures? Transfusion 2006;46:630–5.SchonewilleHvande Watering LMBrandAAdditional red blood cell alloantibodies after blood transfusions in a nonhematologic alloimmunized patient cohort: is it time to take precautionary measures?200646630510.1111/j.1537-2995.2006.00764.x16584440Search in Google Scholar
Schonewille H, de Vries RR, Brand A. Alloimmune response after additional red blood cell antigen challenge in immunized hematooncology patients. Transfusion 2009;49:453–7.SchonewilleHdeVries RRBrandAAlloimmune response after additional red blood cell antigen challenge in immunized hematooncology patients200949453710.1111/j.1537-2995.2008.01980.x19243541Search in Google Scholar
Hellberg A, Poole J, Olsson ML. Molecular basis of the Globoside-deficient Pk blood group phenotype. Identification of four inactivating mutations in the UDP-N-acetylgalactosamine: globotriaosylceramide 3-beta-N-acetylgalactosaminyltransferase gene. J Biol Chem 2002;277: 29455–9.HellbergAPooleJOlssonMLMolecular basis of the Globoside-deficient Pk blood group phenotype200227729455910.1074/jbc.M20304720012023287Search in Google Scholar
Cedergren B. Population studies in northern Sweden. IV. Frequency of the blood type P. Hereditas 1973;73:27–30.CedergrenBPopulation studies in northern Sweden197373273010.1111/j.1601-5223.1973.tb01063.xSearch in Google Scholar
Daniels GL, Fletcher A, Garratty G, et al. Blood group terminology 2004: from the International Society of Blood Transfusion committee on terminology for red cell surface antigens. Vox Sang 2004;87:304–16.DanielsGLFletcherAGarrattyGet alBlood group terminology 2004: from the International Society of Blood Transfusion committee on terminology for red cell surface antigens2004873041610.1111/j.1423-0410.2004.00564.x15585029Search in Google Scholar
Moulds JM, Nowicki S, Moulds JJ, Nowicki BJ. Human blood groups: incidental receptors for viruses and bacteria. J Transfus 1996;36:362–74.MouldsJMNowickiSMouldsJJNowickiBJHuman blood groups: incidental receptors for viruses and bacteria1996363627410.1046/j.1537-2995.1996.36496226154.x8623141Search in Google Scholar
Lindström K, Von Dem Borne AE, Breimer ME, et al. Glycosphingolipid expression in spontaneously aborted fetuses and placenta from blood group p women: evidence for placenta being the primary target for anti-Tja-antibodies. Glycoconj J 1992;9:325–9.LindströmKVonDem Borne AEBreimerMEet alGlycosphingolipid expression in spontaneously aborted fetuses and placenta from blood group p women: evidence for placenta being the primary target for anti-Tja-antibodies19929325910.1007/BF007310931305424Search in Google Scholar
Hagman JR, Hult AK, Westman JS, et al. Multiple miscarriages in two sisters of Thai origin with the rare Pk phenotype caused by a novel nonsense mutation at the B3GALNT1 locus. Transfus Med 2019;29:202–8.HagmanJRHultAKWestmanJSet alMultiple miscarriages in two sisters of Thai origin with the rare Pk phenotype caused by a novel nonsense mutation at the B3GALNT1 locus201929202810.1111/tme.1254429873420Search in Google Scholar
Prince SD, Winestone LE, Nance SJ, Friedman DF. Recurrent Donath-Landsteiner hemolytic anemia: a pediatric case report. Transfusion 2017;57:1401–6.PrinceSDWinestoneLENanceSJFriedmanDFRecurrent Donath-Landsteiner hemolytic anemia: a pediatric case report2017571401610.1111/trf.14032573377828369934Search in Google Scholar
Westman JS, Benktander J, Storry JR, et al. Identification of the molecular and genetic basis of PX2, a glycosphingolipid blood group antigen lacking on globoside-deficient erythrocytes. J Biol Chem 2015;290:18505–18.WestmanJSBenktanderJStorryJRet alIdentification of the molecular and genetic basis of PX2, a glycosphingolipid blood group antigen lacking on globoside-deficient erythrocytes2015290185051810.1074/jbc.M115.655308451311126055721Search in Google Scholar
Chang A, Kim Y, Hoehn R, Jernigan, Pritts T. Cryopreserved packed red blood cells in surgical patients: past, present, and future. Blood Transfus 2017;15:341–7.ChangAKimYHoehnRJerniganPritts TCryopreserved packed red blood cells in surgical patients: past, present, and future2017153417Search in Google Scholar
Cap A, Badloe J, Woolley T, et al. The use of frozen and deglycerolized red blood cells. Mil Med 2018;18:10–52.CapABadloeJWoolleyTet alThe use of frozen and deglycerolized red blood cells201818105210.1093/milmed/usy06130189057Search in Google Scholar
Mastellos DC, Ricklin D, Lambris JD. Clinical promise of next-generation complement therapeutics. Nature Rev Drug Discov 2019;18:707–29.MastellosDCRicklinDLambrisJDClinical promise of next-generation complement therapeutics2019187072910.1038/s41573-019-0031-6734085331324874Search in Google Scholar
Franchini M, Marano G, Veropalumbo E, et al. Patient blood management: a revolutionary approach to transfusion medicine. Blood Transfus 2019;17:191–5.FranchiniMMaranoGVeropalumboEet alPatient blood management: a revolutionary approach to transfusion medicine2019171915Search in Google Scholar
Leahy MF, Hofmann A, Towler S, et al. Improved outcomes and reduced costs associated with a health-system-wide patient blood management program: a retrospective observational study in four major adult tertiary-care hospitals. Transfusion 2017;57:1347–58.LeahyMFHofmannATowlerSet alImproved outcomes and reduced costs associated with a health-system-wide patient blood management program: a retrospective observational study in four major adult tertiary-care hospitals20175713475810.1111/trf.1400628150313Search in Google Scholar